BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Drug Development

  Bay Area’s FibroGen, Inc. Touts Phase 2 Data For Idiopathic Pulmonary Fibrosis Drug FG-3019

  May 19, 2014

   · 

  5 min read
• Drug Development

  In The Battle Of Idiopathic Pulmonary Fibrosis Drugs, Boehringer Ingelheim Corporation’s Nintedanib Wows In Phase 3 Trial

  May 19, 2014

   · 

  2 min read
• Drug Development

  Juventas Therapeutics, Inc. Data Demonstrates Significant Structural, Clinically Meaningful Benefit In Patients With Advanced Heart Failure

  May 19, 2014

   · 

  5 min read
• Business

  Symphogen A/S Finds A New Home, Appoints Chief Manufacturing Officer

  May 19, 2014

   · 

  2 min read
• Deals

  Animal Health Company Parnell Pharmaceuticals Holdings Files For A $58 Million IPO

  May 19, 2014

   · 

  1 min read
• FDA

  FDA Approves IMDx Herpes Assay For Abbott Laboratories’s m2000 System

  May 19, 2014

   · 

  2 min read
• Policy

  Victory For Given Imaging Ltd. As The FDA Downgrades Risk Classification For Pill Camera

  May 19, 2014

   · 

  1 min read
• Pharm Country

  Teleflex Incorporated Announces Pricing Of $250 Million Senior Notes Offering

  May 19, 2014

   · 

  3 min read
• Biotech Bay

  Redwood City’s Coherus Biosciences Locks In $55 Million Series C

  May 19, 2014

   · 

  2 min read
• Biotech Beach

  Activist Investor Oracle Partners Revives Proxy War At BIOLASE Inc.

  May 19, 2014

   · 

  14 min read